Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa ...

CEO and cofounder Joanna Stanicka calls this a huge milestone and says the money will help fund a Phase 1 clinical trial of the firm’s neuropathic pain treatment that is scheduled to begin at ...

Sangamo Therapeutics SGMO is preparing to release its quarterly ... Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; ...

Virios Therapeutics, Inc. ( (DWTX) ) has released its Q3 earnings. Here is a breakdown of the information Virios Therapeutics, Inc. presented ...

Addex Therapeutics (NASDAQ:ADXN – Get Free Report) is scheduled to release its earnings data before the market opens on ...

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

Viking Therapeutics (NASDAQ: VKTX) saw its stock surge over 10% in pre-market trading on November 4, following the release of ...

Dogwood Therapeutics Inc (DWTX) reports significant advancements in clinical trials and secures strategic financing to bolster its pipeline and future development.

Rapport Therapeutics, Inc. ( ($RAPP) ) has released its Q3 earnings. Here is a breakdown of the information Rapport Therapeutics, Inc. presented ...

(Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent ...

Aching knees are surprisingly common. While you may be tempted to hang out on the couch if one or both of your knees hurt, exercise — Pilates in ...

Addex Therapeutics (NASDAQ:ADXN – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Monday, November 11th. Analysts expect the company to announce earnings ...